Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.1M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
588K
-
Shares change
-
-14.5K
-
Total reported value, excl. options
-
$1.31M
-
Value change
-
-$24.5K
-
Number of buys
-
3
-
Number of sells
-
-7
-
Price
-
$2.24
Significant Holders of Indaptus Therapeutics, Inc. - Common Stock (INDP) as of Q1 2024
19 filings reported holding INDP - Indaptus Therapeutics, Inc. - Common Stock as of Q1 2024.
Indaptus Therapeutics, Inc. - Common Stock (INDP) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 588K shares
of 14.1M outstanding shares and own 4.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (256K shares), INVESTMENT HOUSE LLC (102K shares), GEODE CAPITAL MANAGEMENT, LLC (54.8K shares), STRATEGY ASSET MANAGERS LLC (45.3K shares), Pine Valley Investments Ltd Liability Co (44.1K shares), RENAISSANCE TECHNOLOGIES LLC (26.1K shares), Vivaldi Capital Management LP (24K shares), Virtu Financial LLC (14.2K shares), STATE STREET CORP (13.1K shares), and Tower Research Capital LLC (TRC) (4.07K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.